NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN
WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA,
JAPAN, HONG KONG OR THE UNITED STATES
Reference is made to stock exchange notices dated
29 August 2016 and 20 September 2016 regarding a share capital
increase through certain private placements with total gross
proceeds of NOK 165.4 million (the "Private Placements") and a
subsequent offering of up to NOK 13,333,334 (the "Subsequent
Offering").
Hofseth BioCare ASA hereby publishes a prospectus
related to the listing of 11,800,000 new shares issued in a private
placement announced on 22 April 2016 and listing of 110,262,699 new
shares issued in the private placements announced on 26 August 2016
(together the "New Shares") and offering up to 13,333,334 offer
shares in the Subsequent Offering. The Norwegian Financial
Supervisory Authority has reviewed and approved the prospectus.
The prospectus is attached to this stock exchange
notice and will also be made available at the company's website,
www.hofsethbiocare.no. The prospectus is also available at the
company's headquarters at Molovegen 6, 6004 Ålesund, Norway.
It is expected that the New Shares will be
registered in VPS and delivered to the investors today outside
normal trading hours, and that the New Shares will be listed on
Oslo Børs and assume regular trading from and including 3 October
2016.
For further information, please contact:
Jon Olav Ødegård, CFO of Hofseth BioCare ASA
Phone: +47 936 32 966
E-mail: joo@hofsethbiocare.no
About Hofseth BioCare ASA:
HBC is a Norwegian biotech company that offers
high-value ingredients and finished products for humans and pets.
The company is founded on the core values of sustainability,
traceability and optimal utilization of natural resources. Through
an innovative hydrolysis technology, HBC is able to preserve the
quality of salmon oil, proteins and calcium, prepared of fresh
salmon off-cuts. HBC's objective is to contribute to the efficient
use of marine resources and deliver quality products for
ingredients and finished consumer products in the nutrition
market.
Hofseth BioCare's headquarters are located in Ålesund, Norway with
branches in Oslo, Chicago, Mumbai and Tokyo. HBC is listed on Oslo
Stock Exchange Axess list with ticker "HBC". More information about
Hofseth BioCare at www.hofsethbiocare.com and
www.facebook.com/hofsethbiocare
This information is subject
of the disclosure requirements pursuant to section 5-12 of the
Norwegian Securities Trading Act.